Poduri Aruna, Rateri Debra L, Howatt Deborah A, Balakrishnan Anju, Moorleghen Jessica J, Cassis Lisa A, Daugherty Alan
From the Saha Cardiovascular Research Center (A.P., D.L.R., D.A.H., A.B., J.J.M., A.D.) and Department of Molecular and Biomedical Pharmacology (L.A.C.), University of Kentucky, Lexington.
Arterioscler Thromb Vasc Biol. 2015 Sep;35(9):1995-2002. doi: 10.1161/ATVBAHA.115.305995. Epub 2015 Jul 9.
Angiotensin II (Ang II) infusion causes aortic medial thickening via stimulation of angiotensin II type 1a (AT1a) receptors. The purpose of this study was to determine the cellular loci of AT1a receptors that mediate this Ang II-induced aortic pathology.
Saline or Ang II was infused into AT1a receptor floxed mice expressing Cre under control of cell-specific promoters. Initially, AT1a receptors were depleted in aortic smooth muscle cell and endothelium by expressing Cre under control of SM22 and Tie2 promoters, respectively. Deletion of AT1a receptors in either cell type had no effect on Ang II-induced medial thickening. To determine whether this effect was related to neural stimulation, AT1a receptors were depleted using an enolase 2-driven Cre. Depletion of AT1a receptors in neural cells attenuated Ang II-induced medial thickening of the ascending, but not descending aorta. Lineage tracking studies, using ROSA26-LacZ, demonstrated that enolase 2 was also expressed in adventitial cells adjacent to the region of attenuated thickening. To determine whether adventitial fibroblasts contributed to this attenuation, AT1a receptors in fibroblasts were depleted using S100A4 driven Cre. Similar to enolase 2-Cre, Ang II-induced medial thickening was attenuated in the ascending, but not the descending aorta. Lineage tracking demonstrated an increase of S100A4-LacZ positive cells in the media of the ascending region during Ang II infusion.
AT1a receptor depletion in fibroblasts attenuates Ang II-induced medial hyperplasia in the ascending aorta.
输注血管紧张素II(Ang II)通过刺激1a型血管紧张素II(AT1a)受体导致主动脉中膜增厚。本研究的目的是确定介导这种Ang II诱导的主动脉病变的AT1a受体的细胞定位。
将生理盐水或Ang II注入在细胞特异性启动子控制下表达Cre的AT1a受体floxed小鼠体内。最初,分别通过在SM22和Tie2启动子控制下表达Cre,使主动脉平滑肌细胞和内皮细胞中的AT1a受体缺失。两种细胞类型中AT1a受体的缺失对Ang II诱导的中膜增厚均无影响。为了确定这种效应是否与神经刺激有关,使用烯醇化酶2驱动的Cre使AT1a受体缺失。神经细胞中AT1a受体的缺失减弱了Ang II诱导的升主动脉中膜增厚,但对降主动脉无影响。使用ROSA26-LacZ进行的谱系追踪研究表明,烯醇化酶2也在增厚减弱区域相邻的外膜细胞中表达。为了确定外膜成纤维细胞是否促成了这种减弱,使用S100A4驱动的Cre使成纤维细胞中的AT1a受体缺失。与烯醇化酶2-Cre相似,Ang II诱导的升主动脉中膜增厚减弱,但降主动脉未受影响。谱系追踪显示,在输注Ang II期间,升主动脉区域中膜的S100A4-LacZ阳性细胞增加。
成纤维细胞中AT1a受体的缺失减弱了Ang II诱导的升主动脉中膜增生。